Cell type restricted expression of IL15 could potentially be harnessed as a therapeutic towards cancer through the in vitro expansion of NK cells for immunotherapy and the in vitro generation of DCs for induction of tumor-antigen specific CD8+ T cell response39, in an effort to limit immunotoxicity observed in global IL15 administration. This evidence concerns the gene CD8A and neoplasm.